New Model for Breast Cancer Risk in Hispanic Women Is the First to be Based Exclusively on Data From Hispanic Women
The first breast cancer risk-prediction model based entirely on data from Hispanic women, including whether a woman was born in or outside the United States, provides a more accurate assessment of Hispanic women's risk of developing breast cancer.
RNA test of blood platelets can detect, classify, and pinpoint the location of cancer by analyzing a sample equivalent to 1 drop of blood. Using this new method, researchers were able to identify cancer with 96% accuracy.
S-1 is just as effective in terms of overall survival as a taxane as first-line treatment for patients with metastatic breast cancer.
There are no racial disparities in Oncotype DX (ODX) testing for patients with node-negative early breast cancer for ODX testing.
Both in-person and telephone counseling were effective weight loss strategies in breast cancer survivors and resulted in favorable effects.
The use of anastrozole for the prevention of breast cancer was associated with a higher incidence of carpal tunnel syndrome (CTS).
Scientists developed a highly sensitive blood test that indicates when breast cancers become resistant to standard hormone treatment. In addition, the test results can be used to guide further treatment.
New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good health care structures in place.
International Experts Call for Investigations Into Long-Term Management Options for Select Patients With Advanced Breast Cancer
International experts have called for a clinical trial to investigate the best ways for identifying and treating a small but important group of patients with advanced breast cancer who can survive for long periods without their disease progressing.
Depression and antidepressant use may not be associated with increased risk of breast cancer.
Patients With Advanced Breast Cancer Address an International Conference About Misleading Disease-Specific Messages
Patients with advanced breast cancer spoke out about the damaging messages some organizations issue about advanced breast cancer. They need to be identified and educated to change the way they talk about the disease.
The protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in patients with breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.
Use of initial palliative chemotherapy for patients with hormone receptor positive breast cancer is associated with poorer outcomes.
Women receiving chemotherapy for breast cancer have a clinical important risk for developing venous thromboemboli (VTE).
Extent of atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH) does not significantly contribute to breast cancer risk.
Researchers have taken a new approach to understanding why so many patients with breast cancer in Appalachia are not getting the care they need, and their findings are set to change how people view the obstacles to receiving care that beset the region.
Women are prescribed adjuvant therapies after breast cancer surgery to reduce the risk of cancer recurrence. The effects of these therapies have been assumed to remain constant over time, but a new study suggests the opposite is true.
A contributor to persistent racial/ethnic and socioeconomic disparities is limited understanding of the care provided to minority populations.
The addition of ultrasonography increases sensitivity and detection rate of early breast cancers in women aged 40 to 49 years, per a recent study.
A large international study shows that breastfeeding is associated with a lower risk of developing hormone-receptor-negative breast cancer. This breastfeeding meta-analysis shows the risk was reduced by up to 20% in women who breastfed.
A new first-of-its-kind mobile app called Breast Cancer Ally serves as a treatment navigator for patients with breast cancer receiving care.
Venlafaxine has a significant clinical activity against taxane-oxaliplatin-induced acute neurosensory toxicity in patients with cancer.
Parabens, estrogen-mimicking chemicals commonly found in an array of personal care products, may be more dangerous at lower doses than previously thought.
Recent laboratory findings provide novel insight into potential new therapeutic approaches for triple-negative breast cancer, a particularly difficult-to-treat and aggressive form of the disease.
Gene Expression Test Can Lead to More Effective Treatment Decisions In Patients With Invasive Lobular Carcinoma (ILC) Breast Cancer
Most patients with invasive lobular carcinoma (ILC) breast cancer could be treated with hormones alone and not with chemotherapy.
Patients with advanced breast cancer who have higher insulin levels have a significantly worse prognosis than those with normal insulin levels.
In a study conducted to inform American Cancer Society (ACS) breast cancer screening guidelines, a screening mammography once every 2 years was found to be safe for postmenopausal women at average risk of breast cancer.
Regular physical activity could allow women at high-risk of developing breast cancer to delay drastic preventive measures.
Breast cancer rates among African American women have increased to the point that they are converging with rates among white women.
The detection rate of ductal carcinoma in situ (DCIS) on mammography increases with age.
Ever breastfeeding may provide a protective effect against hormone receptor (HR)-negative breast cancers.
Breast radiologist-provided direct public lectures may decrease anxiety and improve knowledge regarding breast cancer screening mammography.
Findings suggest doctors shouldn't automatically rule out less invasive surgery plus radiation for some larger breast tumors.
A surprising, paradoxical relationship between a tumor suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug.
A cool pad pillow topper may be useful as an aid to reduce sleep disturbance and frequency and severity of hot flushes.
The genetic landscape of fibroepithelial tumors has been uncovered. The culprit genes behind the formation and progression of these tumors were identified, potentially improving the diagnostic accuracy of breast cancer and enhancing clinical intervention for patients with this tumor type.
Understanding the Triple Negative Breast Cancer Patient: Tips and Tools for Health Care Professionals
Although treatment options are different and recurrence rates higher for triple negative breast cancer, patients with this subtype of the disease can be hopeful for good treatment outcomes.
The American Cancer Society (ACS) released its updated guidelines for breast cancer screening in women at average risk for developing the disease.
Preteen girls with a family history of breast cancer seem to have similar levels of general anxiety.
Breast conservation therapy (BCT) is standard treatment for breast cancer, but few clinical trials have compared BCT with mastectomy.
The presence of stromal tumor-infiltrating lymphocytes is associated with recurrence-free survival in HER2-positive breast cancer.
Young women undergoing chemotherapy for breast cancer may be more likely to remain fertile if they also receive hormonal treatment, according to new research presented at ECC2015.
Despite advances in treatment, finding smaller tumors has been linked to better survival results.
Detecting breast cancers when they are small still impacts survival despite the various effective therapies.
Previous studies addressed disparities by stage of disease and survival rates, but none of them characterized the patients by disease subtype.
An MR breast imaging technique that uses no ionizing radiation or contrast agent could reduce unnecessary biopsies by providing additional information about suspicious findings on conventional screening mammography, according to a new study.
Computer-aided detection (CAD) in screening mammography is not associated with improved diagnostic accuracy, according to an analysis of results from a large Breast Cancer Surveillance Consortium database of digital screening mammograms.
Researchers are working on a way to use artificial intelligence to predict a patient's response to two common chemotherapy drugs used to treat breast cancer: paclitaxel and gemcitabine.
Metastases cause the vast majority of cancer deaths, but their tiny seeds are so difficult to track. Now, scientists described studying individual metastatic cells from human breast cancer tumors implanted into mice as the cells escaped into the blood stream and began to form tumors elsewhere in the body.
Researchers discovered a new explanation for why women with ER+ breast cancer develop resistance to hormone treatment, and a potential new approach that may overcome the problem.
Although the software can be helpful, it does not appear to improve cancer detection rates.
Pegteograstim is as effective as pegfilgrastim in reducing chemotherapy-induced neutropenia in patients with breast cancer.
An eight-fold increase in preoperative breast MRI was seen over a 10-year period; MRI use was linked to more ancillary investigations.
Brief exposure to a targeted therapy can tell doctors which patients with HER2-negative breast cancer will respond and which should switch to another kind of treatment.
A new study may have uncovered the key to the early detection of patients at risk of developing metastasis to bone.
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone double mastectomy.
Patients with HER2-negative, axillary node-negative breast cancer and favorable 21-gene expression assay score had low rates of recurrence.
Researchers report an increase in breast cancer survivor's use of chronic medication after cancer treatment.
The number of high-risk women deemed eligible for primary prevention may be increased by incorporating benign breast disease (BBD) diagnoses into the Breast Cancer Surveillance Consortium (BCSC) risk model, according to a study.
Magnetic resonance imaging use is increasing in routine preoperative evaluation of women with breast cancer
Study to determine patterns in the utilization of preoperative breast magnetic resonance imaging (MRI) in a health care system with universal insurance.
The cumulative incidence of cardiac events (CE) at 6 years was slightly higher in patients with HER2-positive early breast cancer receiving trastuzumab.
Use of chemotherapy is inverse to disease risk in patients with breast cancer when genetic assay is used
Use of the 21-gene recurrence test score was associated with lower chemotherapy use in high-risk patients and greater use of chemotherapy in low-risk patients compared with not using the test score among a large group of Medicare beneficiaries, according to a recent investigation.
Differences in breast cancer recurrence and survival between African American women and white women are well established.
Chemotherapy-induced peripheral neuropathy (CIPN) was found to be common in a cohort of patients with early stage breast cancer.
Young black women with a breast cancer diagnosis at age 50 years or younger have a much higher BRCA mutation frequency than that previously reported among young white women with breast cancer.
Women who are obese have a higher risk and a worse prognosis for breast cancer, but the reasons why remain unclear.
A national risk model that gauges a woman's chance of developing breast cancer has been refined to give a more accurate assessment.
Women with ductal carcinoma in situ (DCIS) who undergo surgical resection without radiation have an increased risk of developing recurrence.
New software could speed up breast cancer diagnosis with 90% accuracy and without the need for a specialist.
Clinically meaningful weight loss over two years in overweight/obese survivors of breast cancer can be achieved via weight loss intervention.
Researchers estimate the 20-year breast cancer-specific death rate for women diagnosed with ductal carcinoma in situ to be 3.3%.
A high proportion of women who received false-positive results on screening mammography reported experiencing psychosocial consequences or trouble sleeping.
Chemotherapy prolongs life for older adults with most types of cancer, but for women older than 80 years with breast cancer, the chances of improved survival due to chemotherapy are significantly lower, according to a recent study.
The double mastectomy trend mirrors the one seen in women, researchers say.
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis - European Journal of Cancer
A recent study examined the cardiotoxicity of anthracyclines in patients with breast cancer.
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011.
No new safety signals were identified for long-term denosumab therapy in patients with metastatic breast or prostate cancer and bone metastases.
In a study reviewing black women under 50 with invasive breast cancer, 12 percent had BRCA1 or BRCA2 mutations.
Circulating tumor DNA analysis spots stray cells months before scans detect breast cancer recurrence.
Researchers have pinpointed a novel genetic biomarker responsible for the progression of many breast and prostate cancers.
Researchers identify tumor microenvironment of metastasis (TMEM) that allows breast cancer to metastasize
Using high-resolution imaging, scientists have gained a greater understanding of how a doorway in the blood vessel wall allows cancer cells to metastasize.
Findings suggest obesity can trigger structural changes in extracellular matrix, rendering an individual more susceptible to breast cancer.
Researchers have developed a magnetic resonance imaging (MRI) contrast agent with the capability to pinpoint much smaller aggressive breast cancer tumors and micrometastases.
Previous studies have shown that following a 5-year course of tamoxifen after breast cancer treatment can reduce recurrence.
Electroacupuncture may be more effective and safer than gabapentin for managing hot flashes among breast cancer survivors.
Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%.
Radiation to the lymph nodes as well as the standard treatment of whole-breast irradiation after breast-conserving surgery does not confer an overall survival benefit.
A better understanding of the association between barriers to care and clinical outcomes within patient navigation programs.
Breast cancer survivors with a body mass index (BMI) >25 who report the use of tamoxifen therapy may be at increased risk for arm lymphedema.
By surrounding molecules of paclitaxel with self-assembling spheres composed of amino acids, researchers doubled tumor exposure to the drug and reduced its effects on healthy tissue.
[Breast Cancer: Targets and Therapy] This research reviews the preclinical as well as clinical data on neratinib.
Including music therapy as a complementary approach with cancer surgery may help reduce preoperative anxiety.
A behavioral weight loss intervention can produce clinically meaningful weight loss in overweight/obese breast cancer survivors.
A revolutionary alternative to radical mastectomy has been developed that preserves the nipple, areola, and surrounding skin.
The effect of irradiation of regional nodes in patients with stage I, II, or III breast cancer on overall survival is very limited, according to a study.
Multigene testing for hereditary breast and/or ovarian cancer that tests is more likely to inform clinical decision-making than testing for BRCA1/2 alone.
Studies find aromatase inhibitors (AIs) and bisphosphonates improve survival in postmenopausal breast cancer patients
Two new studies suggest that two different classes of drugs, aromatase inhibitors (AIs) and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer.
Melatonin may be a potential therapeutic agent for improve sleep and quality of life in patients with metastatic breast cancer.
Chemotherapy does not improve survival for older women with breast cancer.
Cost of radiotherapy among Medicare patients varied most widely because of year of diagnosis, location of treatment, clinic type, and provider.
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment
- Breakthrough Advance Announced in International Blood Cancer Drug Trial
- Yoga Provides Mental, Emotional, and Physical Benefits for Patients With Cancer
- Citywide Program Increases Rates, Eliminates Racial Disparities in Colorectal Cancer Screening
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- New Blood Test Improves Screening for Prostate Cancer
- Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal Cancer
- International Study Charts Genetic Trajectory for Melanoma
- Risk of Several Autoimmune Diseases Increased in Childhood Cancer Survivors
- Protein Biomarker Assays for Diagnosing Thyroid Cancer May Show Inaccurate Readings
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|